Literature DB >> 3675663

Avidity of anti-Yersinia antibodies in yersiniosis patients with and without Yersinia-triggered reactive arthritis.

R Lahesmaa-Rantala1, O P Lehtonen, K Granfors, A Toivanen.   

Abstract

Avidity of IgM, IgG, and IgA class anti-Yersinia antibodies was compared in sera of 22 patients with yersiniosis and subsequent reactive arthritis versus sera of 22 patients without postinfection complications. An enzyme-linked immunosorbent assay was used for antibody determination. Less than 2 months after onset of the infection, the patients with arthritis had fewer high-avidity IgM antibodies against the bacterial lipopolysaccharide (P = 0.035) and more high-avidity IgA antibodies against bacterial cell extract (P = 0.039) than did the patients without arthritis. This difference increased with time.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675663     DOI: 10.1002/art.1780301015

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis.

Authors:  N Tsuchiya; G Husby; R C Williams
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

Authors:  J Gutiérrez; M Rodríguez; C Maroto; G Piédrola
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Comparison of bacteria with and without plasmid-encoded proteins as antigens for measurement of immunoglobulin M, G, and A antibodies to Yersinia enterocolitica by enzyme-linked immunosorbent assay.

Authors:  K Granfors; R Lahesmaa-Rantala; T H Ståhlberg; A Toivanen
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

Review 4.  Immunological and bacteriological aspects of reactive arthritis.

Authors:  A Toivanen; K Granfors; R Lahesmaa-Rantala; P Toivanen
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

5.  Avidity of antibodies against released proteins of Yersinia spp: comparison of patients with or without reactive arthritis.

Authors:  R Lahesmaa-Rantala; J Heesemann; O P Lehtonen; K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

6.  Oxygen radical production and trapping in subjects with previous Yersinia infection.

Authors:  M Ristola; T Metsä-Ketelä; M Leirisalo-Repo; H Repo
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

7.  Serum opsonic capacity against Yersinia enterocolitica O:3 in yersiniosis patients with or without reactive arthritis.

Authors:  R Tertti; K Granfors; R Lahesmaa-Rantala; A Toivanen
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

8.  Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis.

Authors:  R Merilahti-Palo; K O Söderström; R Lahesmaa-Rantala; K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

9.  Intestinal permeability in patients with yersinia triggered reactive arthritis.

Authors:  R Lahesmaa-Rantala; K E Magnusson; K Granfors; R Leino; T Sundqvist; A Toivanen
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.